Winfree, R. L., Seto, M., Dumitrescu, L., Menon, V., De Jager, P., Wang, Y., Schneider, J., Bennett, D. A., Jefferson, A. L., & Hohman, T. J. (2023). TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia. Acta Neuropathologica, 145(6), 733–747. https://doi.org/10.1007/s00401-023-02564-2

Nichols, E., Brickman, A. M., Casaletto, K. B., Dams‐O’Connor, K., George, K. M., Kumar, R. G., Palta, P., Rabin, J. S., Satizabal, C. L., Schneider, J., Pa, J., & La Joie, R. (2022). AD and non‐AD mediators of the pathway between the APOE genotype and cognition. Alzheimer’s & Dementia, 19(6), 2508–2519. Portico. https://doi.org/10.1002/alz.12885

Habes, M., Jacobson, A. M., Braffett, B. H., Rashid, T., Ryan, C. M., Shou, H., Cui, Y., Davatzikos, C., Luchsinger, J. A., Biessels, G. J., Bebu, I., Gubitosi-Klug, R. A., Bryan, R. N., & Nasrallah, I. M. (2023). Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes. JAMA Network Open, 6(6), e2316182. https://doi.org/10.1001/jamanetworkopen.2023.16182

Horie, K., Li, Y., Barthélemy, N. R., Gordon, B., Hassenstab, J., Benzinger, T. L. S., Fagan, A. M., Morris, J. C., Karch, C. M., Xiong, C., Allegri, R., Mendez, P. C., Ikeuchi, T., Kasuga, K., Noble, J., Farlow, M., Chhatwal, J., Day, G., … Schofield, P. R. (2023). Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer’s Disease. Annals of Neurology, 93(6), 1158–1172. Portico. https://doi.org/10.1002/ana.26620

Kloske, C. M., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Brickman, A. M., Bu, G., Dennison, J., Gearon, M. D., Goate, A. M., Haass, C., Heneka, M. T., Hu, W. T., Huggins, L. K. L., Jones, N. S., Koldamova, R., Lemere, C. A., Liddelow, S. A., Marcora, E., Marsh, S. E., … Carrillo, M. C. (2023). APOE and immunity: Research highlights. Alzheimer’s & Dementia, 19(6), 2677–2696. Portico. https://doi.org/10.1002/alz.13020

Rajabli, F., Tosto, G., Hamilton‐Nelson, K. L., Kunkle, B. W., Vardarajan, B. N., Naj, A., Whitehead, P. G., Gardner, O. K., Bush, W. S., Sariya, S., Mayeux, R. P., Farrer, L. A., Cuccaro, M. L., Vance, J. M., Griswold, A. J., Schellenberg, G. D., Haines, J. L., Byrd, G. S., … Reitz, C. (2022). Admixture mapping identifies novel Alzheimer’s disease risk regions in African Americans. Alzheimer’s & Dementia, 19(6), 2538–2548. Portico. https://doi.org/10.1002/alz.12865

Paschalidis, M., Konstantyner, T. C. R. de O., Simon, S. S., & Martins, C. B. (2023). Trends in mortality from Alzheimer’s disease in Brazil, 2000-2019. Epidemiologia e Serviços de Saúde, 32(2). https://doi.org/10.1590/s2237-96222023000200002

Luo, J., Thomassen, J. Q., Bellenguez, C., Grenier-Boley, B., de Rojas, I., Castillo, A., Parveen, K., Küçükali, F., Nicolas, A., Peters, O., Schneider, A., Dichgans, M., Rujescu, D., Scherbaum, N., Jürgen, D., Riedel-Heller, S., Hausner, L., Porcel, L. M., … Frikke-Schmidt, R. (2023). Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease. JAMA Network Open, 6(5), e2313734. https://doi.org/10.1001/jamanetworkopen.2023.13734

Qiao, M., Lee, A. J., Reyes‐Dumeyer, D., Tosto, G., Faber, K., Goate, A., Renton, A., Chao, M., Boeve, B., Cruchaga, C., Pericak‐Vance, M., Haines, J. L., Rosenberg, R., Tsuang, D., Sweet, R. A., Bennett, D. A., Wilson, R. S., Foroud, T., Mayeux, R., & Vardarajan, B. N. (2023). Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease. Annals of Clinical and Translational Neurology, 10(5), 744–756. Portico. https://doi.org/10.1002/acn3.51757

Wu, R., Tripathy, S., Menon, V., Yu, L., Buchman, A. S., Bennett, D. A., De Jager, P. L., & Lim, A. S. P. (2022). Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer’s disease. Alzheimer’s & Dementia, 19(5), 1888–1900. Portico. https://doi.org/10.1002/alz.12817

Morrone, C. D., Raghuraman, R., Hussaini, S. A., & Yu, W. H. (2023). Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease. Molecular Neurodegeneration, 18(1). https://doi.org/10.1186/s13024-023-00617-4

Oveisgharan, S., Yang, J., Yu, L., Burba, D., Bang, W., Tasaki, S., Grodstein, F., Wang, Y., Zhao, J., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2023). Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology, 100(14). https://doi.org/10.1212/wnl.0000000000206833

Honig, L. S., Kang, M. S., Lee, A. J., Reyes-Dumeyer, D., Piriz, A., Soriano, B., Franco, Y., Coronado, Z. D., Recio, P., Mejía, D. R., Medrano, M., Lantigua, R. A., Teich, A. F., Dage, J. L., & Mayeux, R. (2023). Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity. JAMA Network Open, 6(4), e238214. https://doi.org/10.1001/jamanetworkopen.2023.8214

Palma‐Gudiel, H., Yu, L., Huo, Z., Yang, J., Wang, Y., Gu, T., Gao, C., De Jager, P. L., Jin, P., Bennett, D. A., & Zhao, J. (2022). Fine‐mapping and replication of EWAS loci harboring putative epigenetic alterations associated with AD neuropathology in a large collection of human brain tissue samples. Alzheimer’s & Dementia, 19(4), 1216–1226. Portico. https://doi.org/10.1002/alz.12761

Di, X., Yin, Y., Fu, Y., Mo, Z., Lo, S.-H., DiGuiseppi, C., Eby, D. W., Hill, L., Mielenz, T. J., Strogatz, D., Kim, M., & Li, G. (2023). Detecting mild cognitive impairment and dementia in older adults using naturalistic driving data and interaction-based classification from influence score. Artificial Intelligence in Medicine, 138, 102510. https://doi.org/10.1016/j.artmed.2023.102510

Chatila, Z. K., & Bradshaw, E. M. (2021). Alzheimer’s Disease Genetics: A Dampened Microglial Response? The Neuroscientist, 29(2), 245–263. https://doi.org/10.1177/10738584211024531

Devanand, D. P., Masurkar, A. V., & Wisniewski, T. (2023). Vigorous, regular physical exercise may slow disease progression in Alzheimer’s disease. Alzheimer’s & Dementia, 19(4), 1592–1597. Portico. https://doi.org/10.1002/alz.12946

Rizvi, B., Sathishkumar, M., Kim, S., Márquez, F., Granger, S. J., Larson, M. S., Miranda, B. A., Hollearn, M. K., McMillan, L., Nan, B., Tustison, N. J., Lao, P. J., Brickman, A. M., Greenia, D., Corrada, M. M., Kawas, C. H., & Yassa, M. A. (2023). Posterior white matter hyperintensities are associated with reduced medial temporal lobe subregional integrity and long-term memory in older adults. NeuroImage: Clinical, 37, 103308. https://doi.org/10.1016/j.nicl.2022.103308

Zhu, C. W., Gu, Y., Kociolek, A. J., Fernandez, K. K., Cosentino, S., & Stern, Y. (2023). Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 92(2), 457–466. https://doi.org/10.3233/jad-221021

Chapman, S., Rentería, M. A., Dworkin, J. D., Garriga, S. M., Barker, M. S., Avila-Rieger, J., Gonzalez, C., Joyce, J. L., Vonk, J. M. J., Soto, E., Manly, J. J., Brickman, A. M., Mayeux, R. P., & Cosentino, S. A. (2023). Association of Subjective Cognitive Decline With Progression to Dementia in a Cognitively Unimpaired Multiracial Community Sample. Neurology, 100(10). https://doi.org/10.1212/wnl.0000000000201658

Gouveia Roque, C., Chung, K. M., McCurdy, E. P., Jagannathan, R., Randolph, L. K., Herline-Killian, K., Baleriola, J., & Hengst, U. (2023). CREB3L2-ATF4 heterodimerization defines a transcriptional hub of Alzheimer’s disease gene expression linked to neuropathology. Science Advances, 9(9). https://doi.org/10.1126/sciadv.add2671

Yassine, H. N., Self, W., Kerman, B. E., Santoni, G., Navalpur Shanmugam, N., Abdullah, L., Golden, L. R., Fonteh, A. N., Harrington, M. G., Gräff, J., Gibson, G. E., Kalaria, R., Luchsinger, J. A., Feldman, H. H., Swerdlow, R. H., Johnson, L. A., Albensi, B. C., Zlokovic, B. V., Tanzi, R., … Bowman, G. L. (2022). Nutritional metabolism and cerebral bioenergetics in Alzheimer’s disease and related dementias. Alzheimer’s & Dementia, 19(3), 1041–1066. Portico. https://doi.org/10.1002/alz.12845

Huie, E. Z., Escudero, A., Saito, N., Harvey, D., Nguyen, M.-L., Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., & Dugger, B. N. (2023). TDP-43 Pathology in the Setting of Intermediate and High Alzheimer’s Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. Journal of Alzheimer’s Disease, 91(4), 1291–1301. https://doi.org/10.3233/jad-220558

Fleming, V., Helsel, B. C., Ptomey, L. T., Rosas, H. D., Handen, B., Laymon, C., Christian, B. T., Head, E., Mapstone, M., Lai, F., Krinsky-McHale, S., Zaman, S., Ances, B. M., Lee, J. H., & Hartley, S. L. (2023). Weight Loss and Alzheimer’s Disease in Down Syndrome. Journal of Alzheimer’s Disease, 91(3), 1215–1227. https://doi.org/10.3233/jad-220865

Vöglein, J., Franzmeier, N., Morris, J. C., Dieterich, M., McDade, E., Simons, M., Preische, O., Hofmann, A., Hassenstab, J., Benzinger, T. L., Fagan, A., Noble, J. M., Berman, S. B., Graff‐Radford, N. R., Ghetti, B., Farlow, M. R., Chhatwal, J. P., Salloway, S., … Xiong, C. (2022). Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer’s & Dementia, 19(2), 632–645. Portico. https://doi.org/10.1002/alz.12684

Lauriola, V., Brickman, A. M., Sloan, R. P., & Small, S. A. (2023). Anatomical biology guides a search for nutrients for the aging brain. Molecular Aspects of Medicine, 89, 101154. https://doi.org/10.1016/j.mam.2022.101154

Selles, M. C., Fortuna, J. T. S., Cercato, M. C., Santos, L. E., Domett, L., Bitencourt, A. L. B., Carraro, M. F., Souza, A. S., Janickova, H., Azevedo, C. V., Campos, H. C., de Souza, J. M., Alves-Leon, S., Prado, V. F., Prado, M. A. M., Epstein, A. L., Salvetti, A., Longo, B. M., Arancio, O., … Ferreira, S. T. (2023). AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models. Molecular Therapy, 31(2), 409–419. https://doi.org/10.1016/j.ymthe.2022.11.002

Qu, W., Jeong, A., Zhong, R., Thieschafer, J. S., Gram, A., & Li, L. (2022). Deletion of Small GTPase H-Ras Rescues Memory Deficits and Reduces Amyloid Plaque-Associated Dendritic Spine Loss in Transgenic Alzheimer’s Mice. Molecular Neurobiology, 60(2), 495–511. https://doi.org/10.1007/s12035-022-03082-0

Petrella, J. R., Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., & Doraiswamy, P. M. (2023). Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer’s Disease: A 78-week Randomized Controlled Trial. Journal of Alzheimer’s Disease, 91(1), 483–494. https://doi.org/10.3233/jad-220946

Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S., Lai, F., Rosas, H. D., Lee, J. H., … Xu, X. (2023). Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet Neurology, 22(1), 55–65. https://doi.org/10.1016/s1474-4422(22)00408-2

Turney, I. C., Lao, P. J., Rentería, M. A., Igwe, K. C., Berroa, J., Rivera, A., Benavides, A., Morales, C. D., Rizvi, B., Schupf, N., Mayeux, R., Manly, J. J., & Brickman, A. M. (2023). Brain Aging Among Racially and Ethnically Diverse Middle-Aged and Older Adults. JAMA Neurology, 80(1), 73. https://doi.org/10.1001/jamaneurol.2022.3919

Hani Hojjati, S., Butler, T. A., Chiang, G. C., Habeck, C., RoyChoudhury, A., Feiz, F., Shteingart, J., Nayak, S., Ozoria, S., Fernández, A., Stern, Y., Luchsinger, J. A., Devanand, D. P., & Razlighi, Q. R. (2023). Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness. NeuroImage: Clinical, 38, 103409. https://doi.org/10.1016/j.nicl.2023.103409

Felsky, D., Santa-Maria, I., Cosacak, M. I., French, L., Schneider, J. A., Bennett, D. A., De Jager, P. L., Kizil, C., & Tosto, G. (2023). The Caribbean-Hispanic Alzheimer’s disease brain transcriptome reveals ancestry-specific disease mechanisms. Neurobiology of Disease, 176, 105938. https://doi.org/10.1016/j.nbd.2022.105938

Kim, Y. A., Siddiqui, T., Blaze, J., Cosacak, M. I., Winters, T., Kumar, A., Tein, E., Sproul, A. A., Teich, A. F., Bartolini, F., Akbarian, S., Kizil, C., Hargus, G., & Santa-Maria, I. (2022). RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation. Acta Neuropathologica, 145(1), 29–48. https://doi.org/10.1007/s00401-022-02511-7

Luckett, P. H., Chen, C., Gordon, B. A., Wisch, J., Berman, S. B., Chhatwal, J. P., Cruchaga, C., Fagan, A. M., Farlow, M. R., Fox, N. C., Jucker, M., Levin, J., Masters, C. L., Mori, H., Noble, J. M., Salloway, S., Schofield, P. R., Brickman, A. M., … Brooks, W. S. (2022). Biomarker clustering in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia, 19(1), 274–284. Portico. https://doi.org/10.1002/alz.12661

Kulminski, A. M., Jain‐Washburn, E., Philipp, I., He, L., Loika, Y., Loiko, E., Bagley, O., Ukraintseva, S., Yashin, A., Arbeev, K., Stallard, E., Feitosa, M. F., Schupf, N., Christensen, K., & Culminskaya, I. (2022). APOE ɛ4 allele and TOMM40‐APOC1 variants jointly contribute to survival to older ages. Aging Cell, 21(12). Portico. https://doi.org/10.1111/acel.13730

Vardarajan, B. N., Reyes‐Dumeyer, D., Piriz, A. L., Lantigua, R. A., Medrano, M., Rivera, D., Jiménez‐Velázquez, I. Z., Martin, E., Pericak‐Vance, M. A., Bush, W., Farrer, L., Haines, J. L., Wang, L., Leung, Y. Y., Schellenberg, G., Kukull, W., De Jager, P., Bennett, D. A., Schneider, J. A., … Mayeux, R. (2022). Progranulin mutations in clinical and neuropathological Alzheimer’s disease. Alzheimer’s & Dementia, 18(12), 2458–2467. Portico. https://doi.org/10.1002/alz.12567

Lee, A., Kondapalli, C., Virga, D. M., Lewis, T. L., Koo, S. Y., Ashok, A., Mairet-Coello, G., Herzig, S., Foretz, M., Viollet, B., Shaw, R., Sproul, A., & Polleux, F. (2022). Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-32130-5

Gomes, P., Tzouanou, F., Skolariki, K., Vamvaka-Iakovou, A., Noguera-Ortiz, C., Tsirtsaki, K., Waites, C. L., Vlamos, P., Sousa, N., Costa-Silva, B., Kapogiannis, D., & Sotiropoulos, I. (2022). Extracellular vesicles and Alzheimer’s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment. Experimental Neurology, 358, 114183. https://doi.org/10.1016/j.expneurol.2022.114183

Priemer, D. S., Rhodes, C. H., Karlovich, E., Perl, D. P., & Goldman, J. E. (2022). Aβ Deposits in the Neocortex of Adult and Infant Hypoxic Brains, Including in Cases of COVID-19. Journal of Neuropathology & Experimental Neurology, 81(12), 988–995. https://doi.org/10.1093/jnen/nlac095

Mielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., Foldi, N. S., Franzen, S., Gilsanz, P., Li, W., McManus, A. J., van Lent, D. M., Milani, S. A., Shaaban, C. E., … Stites, S. D. (2022). Consideration of sex and gender in Alzheimer’s disease and related disorders from a global perspective. Alzheimer’s & Dementia, 18(12), 2707–2724. Portico. https://doi.org/10.1002/alz.12662

Schoemaker, D., Zanon Zotin, M. C., Chen, K., Igwe, K. C., Vila-Castelar, C., Martinez, J., Baena, A., Fox-Fuller, J. T., Lopera, F., Reiman, E. M., Brickman, A. M., & Quiroz, Y. T. (2022). White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia. Alzheimer’s Research & Therapy, 14(1). https://doi.org/10.1186/s13195-022-01030-7

Luquez, T., Gaur, P., Kosater, I. M., Lam, M., Lee, D. I., Mares, J., Paryani, F., Yadav, A., & Menon, V. (2022). Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease. Genome Medicine, 14(1). https://doi.org/10.1186/s13073-022-01136-5

Siddiqui, T., Celikkaya, H., Atasavum, Z. T., Popova, S., Freudenberg, U., Werner, C., & Kizil, C. (2022). Three-Dimensional Biohybrid StarPEG–Heparin Hydrogel Cultures for Modeling Human Neuronal Development and Alzheimer’s Disease Pathology. Alzheimer’s Disease, 159–170. https://doi.org/10.1007/978-1-0716-2655-9_8

Tropea, M. R., Gulisano, W., Vacanti, V., Arancio, O., Puzzo, D., & Palmeri, A. (2022). Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease. Free Radical Biology and Medicine, 193, 657–668. https://doi.org/10.1016/j.freeradbiomed.2022.11.022

Iturria-Medina, Y., Adewale, Q., Khan, A. F., Ducharme, S., Rosa-Neto, P., O’Donnell, K., Petyuk, V. A., Gauthier, S., De Jager, P. L., Breitner, J., & Bennett, D. A. (2022). Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Science Advances, 8(46). https://doi.org/10.1126/sciadv.abo6764

Yu, L., Hsieh, Y.-C., Pearse, R. V., Wang, Y., Petyuk, V. A., Schneider, J. A., Buchman, A. S., Seyfried, N. T., De Jager, P. L., Young-Pearse, T. L., & Bennett, D. A. (2022). Association of AK4 Protein From Stem Cell–Derived Neurons With Cognitive Reserve. Neurology, 99(20). https://doi.org/10.1212/wnl.0000000000201120

Ostrowitzki, S., Bittner, T., Sink, K. M., Mackey, H., Rabe, C., Honig, L. S., Cassetta, E., Woodward, M., Boada, M., van Dyck, C. H., Grimmer, T., Selkoe, D. J., Schneider, A., Blondeau, K., Hu, N., Quartino, A., Clayton, D., Dolton, M., Dang, Y., … Doody, R. S. (2022). Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease. JAMA Neurology, 79(11), 1113. https://doi.org/10.1001/jamaneurol.2022.2909

Pan, X., Zhang, D., Heo, J. H., Park, C., Li, G., Dengler-Crish, C. M., Li, Y., Gu, Y., Young, H. N., Lavender, D. L., & Shi, L. (2022). Antihypertensive Use and the Risk of Alzheimer’s Disease and Related Dementias among Older Adults in the USA. Drugs & Aging, 39(11), 875–886. https://doi.org/10.1007/s40266-022-00981-8

Joseph‐Mathurin, N., Llibre‐Guerra, J. J., Li, Y., McCullough, A. A., Hofmann, C., Wojtowicz, J., Park, E., Wang, G., Preboske, G. M., Wang, Q., Gordon, B. A., Chen, C. D., Flores, S., Aggarwal, N. T., Berman, S. B., Bird, T. D., Black, S. E., Borowski, B., … Brooks, W. S. (2022). Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Annals of Neurology, 92(5), 729–744. Portico. https://doi.org/10.1002/ana.26511